{"id":"https://openalex.org/W7225464649","doi":"https://doi.org/10.56098/qt8y6390","title":"Sclerosing Activity and Thrombogenic Potential of a COVID-19 mRNA Vaccine Metabolite: New Evidence of Its Contribution to the Pathogenesis of Adverse Cardiovascular Reactions, Including Fatal Outcomes","display_name":"Sclerosing Activity and Thrombogenic Potential of a COVID-19 mRNA Vaccine Metabolite: New Evidence of Its Contribution to the Pathogenesis of Adverse Cardiovascular Reactions, Including Fatal Outcomes","publication_year":2026,"publication_date":"2026-11-07","ids":{"openalex":"https://openalex.org/W7225464649","doi":"https://doi.org/10.56098/qt8y6390"},"language":"en","primary_location":{"id":"doi:10.56098/qt8y6390","doi":"https://doi.org/10.56098/qt8y6390","is_oa":true,"landing_page_url":"https://doi.org/10.56098/qt8y6390","pdf_url":"https://ijvtpr.com/index.php/IJVTPR/article/download/131/463","source":{"id":"https://openalex.org/S4387280470","display_name":"International Journal of Vaccine Theory Practice and Research","issn_l":"2766-5852","issn":["2766-5852"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Vaccine Theory, Practice, and Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ijvtpr.com/index.php/IJVTPR/article/download/131/463","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161222736","display_name":"Gabrielle Segalla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gabrielle Segalla","raw_affiliation_strings":["Multichem R&D"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multichem R&D","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5161222736"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"2","first_page":"1755","last_page":"1762"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.788100004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.12110000103712082,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.02070000022649765,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19-mrna-vaccine","display_name":"COVID-19 mRNA vaccine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/bnt162b2","display_name":"BNT162b2","score":0.9710000157356262},{"id":"https://openalex.org/keywords/alc-0315","display_name":"ALC-0315","score":0.9160000085830688},{"id":"https://openalex.org/keywords/sclerosing-agents","display_name":"sclerosing agents","score":0.9020000100135803},{"id":"https://openalex.org/keywords/detergent-surfactants","display_name":"detergent surfactants","score":0.7200000286102295},{"id":"https://openalex.org/keywords/membrane-damage","display_name":"membrane damage","score":0.7739999890327454},{"id":"https://openalex.org/keywords/endothelial-injury","display_name":"endothelial injury","score":0.8989999890327454},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pericarditis","display_name":"pericarditis","score":0.9559999704360962},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.8759999871253967},{"id":"https://openalex.org/keywords/phlebitis","display_name":"phlebitis","score":0.6690000295639038},{"id":"https://openalex.org/keywords/mitochondrial-fatty-acid-beta-oxidation","display_name":"mitochondrial beta-oxidation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/precautionary-principle","display_name":"precautionary principle","score":0.8539999723434448},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.7544999718666077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7476999759674072},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6233999729156494},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5842000246047974},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.38179999589920044},{"id":"https://openalex.org/C2781001862","wikidata":"https://www.wikidata.org/wiki/Q501561","display_name":"Pericarditis","level":2,"score":0.3555000126361847},{"id":"https://openalex.org/C2780875844","wikidata":"https://www.wikidata.org/wiki/Q186235","display_name":"Myocarditis","level":2,"score":0.3456999957561493},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.31529998779296875},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.31119999289512634},{"id":"https://openalex.org/C2776714567","wikidata":"https://www.wikidata.org/wiki/Q7861081","display_name":"Typhoid vaccine","level":3,"score":0.30239999294281006},{"id":"https://openalex.org/C2992046845","wikidata":"https://www.wikidata.org/wiki/Q170065","display_name":"Infectious agent","level":3,"score":0.2946000099182129},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2935999929904938},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2637999951839447},{"id":"https://openalex.org/C6929976","wikidata":"https://www.wikidata.org/wiki/Q3771881","display_name":"Regulator","level":3,"score":0.2587999999523163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.56098/qt8y6390","doi":"https://doi.org/10.56098/qt8y6390","is_oa":true,"landing_page_url":"https://doi.org/10.56098/qt8y6390","pdf_url":"https://ijvtpr.com/index.php/IJVTPR/article/download/131/463","source":{"id":"https://openalex.org/S4387280470","display_name":"International Journal of Vaccine Theory Practice and Research","issn_l":"2766-5852","issn":["2766-5852"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Vaccine Theory, Practice, and Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.56098/qt8y6390","doi":"https://doi.org/10.56098/qt8y6390","is_oa":true,"landing_page_url":"https://doi.org/10.56098/qt8y6390","pdf_url":"https://ijvtpr.com/index.php/IJVTPR/article/download/131/463","source":{"id":"https://openalex.org/S4387280470","display_name":"International Journal of Vaccine Theory Practice and Research","issn_l":"2766-5852","issn":["2766-5852"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Vaccine Theory, Practice, and Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225464649.pdf","grobid_xml":"https://content.openalex.org/works/W7225464649.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1971656059","https://openalex.org/W1976047558","https://openalex.org/W1977026381","https://openalex.org/W1978230953","https://openalex.org/W2016716965","https://openalex.org/W2034510791","https://openalex.org/W2048044810","https://openalex.org/W2133003438","https://openalex.org/W2337809032","https://openalex.org/W2484188204","https://openalex.org/W2954782052","https://openalex.org/W3160863677","https://openalex.org/W3217355073","https://openalex.org/W4225125278","https://openalex.org/W4290777003","https://openalex.org/W4318070609","https://openalex.org/W4387666559","https://openalex.org/W4390863440","https://openalex.org/W4391294352","https://openalex.org/W4392518885","https://openalex.org/W4400172404","https://openalex.org/W4401630028","https://openalex.org/W4407886726","https://openalex.org/W7139029689","https://openalex.org/W7161584730","https://openalex.org/W7164008084","https://openalex.org/W7222663218"],"related_works":["https://openalex.org/W7161584730","https://openalex.org/W4327726434","https://openalex.org/W4302303593","https://openalex.org/W4379522502","https://openalex.org/W4290999290","https://openalex.org/W4213197515","https://openalex.org/W3211329967","https://openalex.org/W4206842700","https://openalex.org/W4403993512","https://openalex.org/W4220902933"],"abstract_inverted_index":{"A":[0],"previous":[1],"study":[2],"published":[3],"in":[4,11,22],"this":[5],"journal":[6],"identified":[7],"a":[8,104,153],"fundamental":[9],"inconsistency":[10],"the":[12,20,23,26,33,41,49,92,98,113,121,135,161],"pharmacokinetic":[13],"dossiers":[14],"for":[15,134],"Pfizer/BioNTech\u2019s":[16],"Comirnaty":[17],"mRNA":[18],"vaccine:":[19],"substitution,":[21],"documentation,":[24],"of":[25,51,97,101,115,137,160],"actual":[27],"ALC-0315":[28],"metabolite,":[29],"2-hexyldecanoic":[30,80,102],"acid,":[31,103],"with":[32,112],"\u201cphantom\u201d,":[34],"untraceable":[35],"isomer":[36],"6-hexyldecanoic":[37],"acid.":[38],"Beyond":[39],"circumventing":[40],"Aquatic":[42],"Chronic":[43],"1":[44],"(H410)":[45],"toxicological":[46],"classification":[47],"and":[48,64,82,94,107,120,131,146],"inhibition":[50],"mitochondrial":[52],"\u03b2-oxidation":[53],"attributable":[54],"to":[55,69],"steric":[56],"hindrance":[57],"from":[58],"branching":[59],"at":[60],"C2,":[61],"chemical,":[62],"historical":[63],"pharmacological":[65],"evidence":[66],"now":[67],"points":[68],"substantially":[70],"more":[71],"serious":[72],"concerns.":[73],"Authoritative":[74],"chemical":[75,118],"reference":[76],"works":[77],"explicitly":[78],"classify":[79],"acid":[81],"its":[83,109],"sodium":[84],"salt":[85],"as":[86],"\u201csclerosing":[87],"agents\u201d.":[88],"This":[89],"review":[90],"examines":[91],"membrane-disruptive":[93],"endothelium-damaging":[95],"activity":[96],"anionic":[99],"form":[100],"detergent":[105],"surfactant,":[106],"analyses":[108],"direct":[110],"relationship":[111],"induction":[114],"tissue":[116],"necrosis,":[117],"phlebitis":[119],"ensuing":[122],"thrombogenic":[123],"cascade.":[124],"These":[125],"mechanisms":[126],"provide":[127],"an":[128,157],"incontrovertible":[129],"biochemical":[130],"aetiopathogenic":[132],"rationale":[133],"occurrence":[136],"severe":[138],"cardiovascular":[139],"adverse":[140],"events":[141],"-":[142,148],"including":[143],"thrombosis,":[144],"myocarditis":[145],"pericarditis":[147],"observed":[149],"after":[150],"vaccination":[151],"on":[152],"large":[154],"scale,":[155],"constituting":[156],"unprecedented":[158],"violation":[159],"Precautionary":[162],"Principle.":[163]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-08T00:00:00"}